{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:09Z","timestamp":1787020869349,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13063-016-1657-x","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T00:44:30Z","timestamp":1477615470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The effectiveness of the paclitaxel-coated Luminor\u00ae balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"17","author":[{"given":"U.","family":"Teichgr\u00e4ber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Aschenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Scheinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brechtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Thieme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Blessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Treitl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lichtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"von Flowtow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Werk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Riambau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wienke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sixt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,28]]},"reference":[{"key":"1657_CR1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","volume":"110","author":"B Scheller","year":"2004","unstructured":"Scheller B, Speck U, Abramjuk C, Bernhardt U, B\u00f6hm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810\u20134.","journal-title":"Circulation"},{"issue":"105-14","key":"1657_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1586\/erd.12.67","volume":"10","author":"B Schnorr","year":"2013","unstructured":"Schnorr B, Albrecht T. Drug-coated balloons and their place in treating peripheral arterial disease. Expert Rev Med Devices. 2013;10(105-14):105\u201314. doi: 10.1586\/erd.12.67 .","journal-title":"Expert Rev Med Devices"},{"key":"1657_CR3","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","volume":"118","author":"M Werk","year":"2008","unstructured":"Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358\u201365. doi: 10.1161\/CIRCULATIONAHA.107.735985 .","journal-title":"Circulation"},{"key":"1657_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa0706356","volume":"358","author":"G Tepe","year":"2008","unstructured":"Tepe G, Zeller T, Albrecht T, Heller S, Schwarzw\u00e4lder U, Beregi JP, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689\u201399. doi: 10.1056\/NEJMoa0706356 .","journal-title":"N Engl J Med"},{"key":"1657_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","volume":"5","author":"M Werk","year":"2012","unstructured":"Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5:831\u201340. doi: 10.1161\/CIRCINTERVENTIONS.112.971630 .","journal-title":"Circ Cardiovasc Interv"},{"issue":"Suppl 1","key":"1657_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","volume":"33","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1\u201375. doi: 10.1016\/j.ejvs.2006.09.024 .","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1657_CR7","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1161\/CIRCULATIONAHA105.570093","volume":"112","author":"L Mauri","year":"2005","unstructured":"Mauri L, Orav EJ, Candia SC, Cutlip DE, Kuntz RE. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation. 2005;112:2833\u20139. doi: 10.1161\/CIRCULATIONAHA105.570093 .","journal-title":"Circulation"},{"key":"1657_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","volume":"7","author":"D Scheinert","year":"2014","unstructured":"Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosier M, et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014;7:10\u20139. doi: 10.1016\/j.jcin.2013.05.022 .","journal-title":"JACC Cardiovasc Interv"},{"key":"1657_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jcin.2011.11.010","volume":"5","author":"A Micari","year":"2012","unstructured":"Micari A, Cioppa A, Vadal\u00e0 G, Castriota F, Liso A, Marchese A, et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. JACC Cardiovasc Interv. 2012;5:331\u20138. doi: 10.1016\/j.jcin.2011.11.010 .","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"1657_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/CIRCINTERVENTIONS.112.969972","volume":"5","author":"S Cassese","year":"2012","unstructured":"Cassese S, Byrne RA, Ott I, Ndrepepa G, Nerad M, Kastrati A, Fusaro M. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv. 2012;5(4):582\u20139. doi: 10.1161\/CIRCINTERVENTIONS.112.969972 .","journal-title":"Circ Cardiovasc Interv"},{"key":"1657_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1526602814564383","volume":"22","author":"D Scheinert","year":"2015","unstructured":"Scheinert D, Schulte KL, Zeller T, et al. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results From the BIOLUX P-I randomized trial. J Endovasc Ther. 2015;22:14\u201321. doi: 10.1177\/1526602814564383 .","journal-title":"J Endovasc Ther"},{"issue":"1","key":"1657_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1583\/13-4420R.1","volume":"21","author":"F Liistro","year":"2014","unstructured":"Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study. J Endovasc Ther. 2014;21(1):1\u20138. doi: 10.1583\/13-4420R.1 .","journal-title":"J Endovasc Ther"},{"issue":"2","key":"1657_CR13","first-page":"207","volume":"55","author":"F Fanelli","year":"2014","unstructured":"Fanelli F, Cannavale A, Corona M, Lucatelli P, Wlderk A, Salvatori FM. The \u201cDEBELLUM\u201d\u2014lower limb multilevel treatment with drug eluting balloon\u2014randomized trial: 1-year results. J Cardiovasc Surg. 2014;55(2):207\u201316.","journal-title":"J Cardiovasc Surg"},{"key":"1657_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131:495\u2013502. doi: 10.1161\/CIRCULATIONAHA.114.011004 .","journal-title":"Circulation"},{"issue":"21","key":"1657_CR15","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","volume":"66","author":"JR Laird","year":"2015","unstructured":"Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, Krishnan P, Scheinert D, Micari A, Cohen DJ, Wang H, Hasenbank MS, Jaff MR. IN.PACT SFA Trial Investigators. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol. 2015;66(21):2329\u201338. doi: 10.1016\/j.jacc.2015.09.063 . Epub 2015 Oct 14.","journal-title":"J Am Coll Cardiol"},{"key":"1657_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1406235","volume":"373","author":"K Rosenfield","year":"2015","unstructured":"Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, M\u00fcller-H\u00fclsbeck S, Nehler MR, Benenati JF, Scheinert D, LEVANT 2 Investigators. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373:145\u201353. doi: 10.1056\/NEJMoa1406235 .","journal-title":"N Engl J Med"},{"issue":"1 Pt A","key":"1657_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023.PMID:25616822","volume":"8","author":"G Tepe","year":"2015","unstructured":"Tepe G, Schnorr B, Albrecht T, Brechtel K, Claussen CD, Scheller B, Speck U, Zeller T. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv. 2015;8(1 Pt A):102\u20138. doi: 10.1016\/j.jcin.2014.07.023.PMID:25616822 .","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"1657_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ccd.25900","volume":"86","author":"H Schroeder","year":"2015","unstructured":"Schroeder H, Meyer DR, Lux B, Ruecker F, Martorana M, Duda S. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study. Catheter Cardiovasc Interv. 2015;86(2):278\u201386. doi: 10.1002\/ccd.25900 .","journal-title":"Catheter Cardiovasc Interv"}],"updated-by":[{"DOI":"10.1186\/s13063-017-1884-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1657-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:18:15Z","timestamp":1498342695000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-016-1657-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,28]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1657"],"URL":"https:\/\/doi.org\/10.1186\/s13063-016-1657-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,28]]},"article-number":"528"}}